Boston Trust Walden
WST icon

Boston Trust Walden’s West Pharmaceutical WST Stock Holding History

Boston Trust Walden’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$29M Sell
78,232
-2,999
-4% -$1.06M 0.23% 143
2026
Q2 		$29.2M Buy
+81,231
New +$24.8M 0.22% 153
2025
Q2 		– Sell
-1,110
Closed -$249K – 384
2025
Q1 		$249K Buy
1,110
+50
+5% +$13.8K ﹤0.01% 359
2024
Q4 		$347K Sell
1,060
-50
-5% -$15.7K ﹤0.01% 341
2024
Q3 		$333K Hold
1,110
– – ﹤0.01% 341
2024
Q2 		$366K Sell
1,110
-100
-8% -$35.3K ﹤0.01% 336
2024
Q1 		$479K Sell
1,210
-12,237
-91% -$4.53M ﹤0.01% 317
2023
Q4 		$4.73M Sell
13,447
-4,421
-25% -$1.56M 0.04% 224
2023
Q3 		$6.7M Sell
17,868
-227
-1% -$87.8K 0.06% 211
2023
Q2 		$6.92M Sell
18,095
-11,815
-40% -$4.22M 0.06% 214
2023
Q1 		$10.4M Sell
29,910
-4,605
-13% -$1.35M 0.09% 197
2022
Q4 		$8.12M Buy
+34,515
New +$8.18M 0.07% 212
2016
Q3 		– Sell
-34,829
Closed -$2.64M – 348
2016
Q2 		$2.64M Sell
34,829
-205,623
-86% -$15M 0.05% 250
2016
Q1 		$16.7M Sell
240,452
-83,418
-26% -$5.02M 0.29% 138
2015
Q4 		$19.5M Sell
323,870
-493,173
-60% -$29.7M 0.36% 107
2015
Q3 		$44.2M Sell
817,043
-34,554
-4% -$2.01M 0.74% 33
2015
Q2 		$49.5M Sell
851,597
-266,335
-24% -$14.9M 0.75% 30
2015
Q1 		$67.3M Sell
1,117,932
-69,104
-6% -$3.68M 1% 14
2014
Q4 		$63.2M Sell
1,187,036
-238,189
-17% -$11.9M 0.94% 17
2014
Q3 		$63.8M Sell
1,425,225
-66,922
-4% -$2.84M 0.99% 13
2014
Q2 		$62.9M Buy
1,492,147
+19,516
+1% +$836K 0.91% 16
2014
Q1 		$64.9M Sell
1,472,631
-31,115
-2% -$1.46M 0.96% 12
2013
Q4 		$73.8M Sell
1,503,746
-72,435
-5% -$3.39M 1.08% 6
2013
Q3 		$64.9M Sell
1,576,181
-50,173
-3% -$1.91M 0.99% 9
2013
Q2 		$57.1M Buy
+1,626,354
New +$53.5M 0.92% 17

Other funds holding WST

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Boston Trust Walden's WST Position: Q3 2026 in Review

Boston Trust Walden reduced its West Pharmaceutical (WST) stake by 3.7% in Q3 2026, selling an estimated $1.06M and leaving 78,232 shares worth $29M. The position accounts for 0.23% of the portfolio, ranked #143.

Boston Trust Walden first reported a position in WST in Q2 2013 and has held it in 25 quarters since. The position peaked at $73.8M in Q4 2013. 430 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Boston Trust Walden held 78,232 shares of West Pharmaceutical worth $29M as of Q3 2026.
  • Boston Trust Walden sold 2,999 West Pharmaceutical shares in Q3 2026, an estimated $1.06M.
  • West Pharmaceutical made up 0.23% of Boston Trust Walden's portfolio in Q3 2026, its #143 holding.
  • Boston Trust Walden first reported a position in West Pharmaceutical in Q2 2013 and has held it in 25 quarters since.
  • Boston Trust Walden's West Pharmaceutical position peaked at $73.8M in Q4 2013.
  • 430 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Boston Trust Walden's 13F filing for Q3 2026, filed 30 Oct 2026.